Burning Rock Biotech Limited (BNR)
NASDAQ: BNR · Real-Time Price · USD
9.78
+0.53 (5.73%)
At close: Aug 21, 2026, 4:00 PM EDT
9.70
-0.08 (-0.82%)
After-hours: Aug 21, 2026, 7:30 PM EDT
Burning Rock Biotech Market Cap
Burning Rock Biotech has a market cap or net worth of $103.14 million as of August 21, 2026. Its market cap has increased by 3.01% in one year.
Market Cap
103.14M
Enterprise Value
45.86M
1-Year Change
3.01%
Ranking
Category
Stock Price
$9.78
ChartMarket Cap Chart
Since June 12, 2020, Burning Rock Biotech's market cap has decreased from $2.51B to $103.14M, a decrease of -95.89%. That is a compound annual growth rate of -40.25%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 103.14M | -52.46% |
| Dec 31, 2025 | 216.95M | 213.30% |
| Dec 31, 2024 | 69.25M | -29.38% |
| Dec 29, 2023 | 98.06M | -58.57% |
| Dec 30, 2022 | 236.67M | -76.25% |
| Dec 31, 2021 | 996.35M | -58.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 12, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| OPKO Health | 1.12B |
| Castle Biosciences | 1.03B |
| Fulgent Genetics | 547.00M |
| Myriad Genetics | 308.95M |
| Biodesix | 267.68M |
| Exagen | 189.20M |
| Insight Molecular Diagnostics | 144.97M |
| Quantum Cyber | 107.61M |